Table 2 GO enrichment analyses revealed significant (p-value ≤0.05) GO terms and associated enriched genes in the biological process (BP), cellular component (CC), and molecular function (MF) categories
From: Genome-wide identification of methylated CpG sites in nongenital cutaneous warts
Category | Term | P-value | Genes |
|---|---|---|---|
MF | GO:0017124 ~ SH3 domain binding | 0.004 | ARHGAP31, ZNF106, SYNGAP1, CIT |
MF | GO:0003779 ~ actin binding | 0.006 | NCALD, WASF1, DAAM1, MPRIP, MYO5C |
MF | GO:0005096 ~ GTPase activator activity | 0.006 | ARHGAP31, RAP1GAP, SIPA1L1, SYNGAP1, ARHGEF10L |
BP | GO:0043087 ~ regulation of GTPase activity | 0.014 | RAP1GAP, SIPA1L1, SYNGAP1 |
BP | GO:0043547 ~ positive regulation of GTPase activity | 0.019 | ARHGAP31, RAP1GAP, PTPRA, RAPGEF4, SYNGAP1, ARHGEF10L |
CC | GO:0045211 ~ postsynaptic membrane | 0.019 | SIPA1L1, TENM2, TANC1, GRID1 |
BP | GO:0016337 ~ single organismal cell-cell adhesion | 0.031 | TENM2, PKD1, PKD1L1 |
BP | GO:0050982 ~ detection of mechanical stimulus | 0.038 | PKD1, PKD1L1 |
MF | GO:0017016 ~ Ras GTPase binding | 0.039 | RAP1GAP, RAPGEF4 |
BP | GO:0010832 ~ negative regulation of myotube differentiation | 0.043 | HDAC4, BHLHE41 |
BP | GO:0018105 ~ peptidyl-serine phosphorylation | 0.046 | MAST2, PKD1, PRKD3 |